Dose-dependent effects of oral acyclovir in the incubation period of varicella

S. Suga, Tetsushi Yoshikawa, T. Yazaki, T. Ozaki, Y. Asano

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Dose of acyclovir (ACV) and clinical features of varicella were evaluated in 65 household contacts (0.8-9 y) who received oral ACV (5-80 mg/kg daily in four divided doses) during the latter half of the incubation period of varicella. The severity of the disease was compared with that of 23 children who did not receive ACV. Infection was confirmed by a fluorescent antibody to membrane antigen assay. The antibody titers and the rate of apparent infection increased as the dose of ACV administered decreased. The number of skin lesions in patients who received ACV was significantly reduced when compared to the control group. These data suggest dose-dependence of ACV for modification of varicella during secondary viremia in the incubation of the disease.

Original languageEnglish
Pages (from-to)1418-1421
Number of pages4
JournalActa Paediatrica, International Journal of Paediatrics
Volume85
Issue number12
DOIs
Publication statusPublished - 01-01-1996

Fingerprint

Acyclovir
Chickenpox
Antibodies
Viremia
Infection
Antigens
Control Groups
Skin
Membranes

All Science Journal Classification (ASJC) codes

  • Pediatrics, Perinatology, and Child Health

Cite this

@article{6a95c58b239043cf9e327f1ca8578d10,
title = "Dose-dependent effects of oral acyclovir in the incubation period of varicella",
abstract = "Dose of acyclovir (ACV) and clinical features of varicella were evaluated in 65 household contacts (0.8-9 y) who received oral ACV (5-80 mg/kg daily in four divided doses) during the latter half of the incubation period of varicella. The severity of the disease was compared with that of 23 children who did not receive ACV. Infection was confirmed by a fluorescent antibody to membrane antigen assay. The antibody titers and the rate of apparent infection increased as the dose of ACV administered decreased. The number of skin lesions in patients who received ACV was significantly reduced when compared to the control group. These data suggest dose-dependence of ACV for modification of varicella during secondary viremia in the incubation of the disease.",
author = "S. Suga and Tetsushi Yoshikawa and T. Yazaki and T. Ozaki and Y. Asano",
year = "1996",
month = "1",
day = "1",
doi = "10.1111/j.1651-2227.1996.tb13945.x",
language = "English",
volume = "85",
pages = "1418--1421",
journal = "Acta Paediatrica, International Journal of Paediatrics",
issn = "0803-5253",
publisher = "Wiley-Blackwell",
number = "12",

}

Dose-dependent effects of oral acyclovir in the incubation period of varicella. / Suga, S.; Yoshikawa, Tetsushi; Yazaki, T.; Ozaki, T.; Asano, Y.

In: Acta Paediatrica, International Journal of Paediatrics, Vol. 85, No. 12, 01.01.1996, p. 1418-1421.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Dose-dependent effects of oral acyclovir in the incubation period of varicella

AU - Suga, S.

AU - Yoshikawa, Tetsushi

AU - Yazaki, T.

AU - Ozaki, T.

AU - Asano, Y.

PY - 1996/1/1

Y1 - 1996/1/1

N2 - Dose of acyclovir (ACV) and clinical features of varicella were evaluated in 65 household contacts (0.8-9 y) who received oral ACV (5-80 mg/kg daily in four divided doses) during the latter half of the incubation period of varicella. The severity of the disease was compared with that of 23 children who did not receive ACV. Infection was confirmed by a fluorescent antibody to membrane antigen assay. The antibody titers and the rate of apparent infection increased as the dose of ACV administered decreased. The number of skin lesions in patients who received ACV was significantly reduced when compared to the control group. These data suggest dose-dependence of ACV for modification of varicella during secondary viremia in the incubation of the disease.

AB - Dose of acyclovir (ACV) and clinical features of varicella were evaluated in 65 household contacts (0.8-9 y) who received oral ACV (5-80 mg/kg daily in four divided doses) during the latter half of the incubation period of varicella. The severity of the disease was compared with that of 23 children who did not receive ACV. Infection was confirmed by a fluorescent antibody to membrane antigen assay. The antibody titers and the rate of apparent infection increased as the dose of ACV administered decreased. The number of skin lesions in patients who received ACV was significantly reduced when compared to the control group. These data suggest dose-dependence of ACV for modification of varicella during secondary viremia in the incubation of the disease.

UR - http://www.scopus.com/inward/record.url?scp=0029796001&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029796001&partnerID=8YFLogxK

U2 - 10.1111/j.1651-2227.1996.tb13945.x

DO - 10.1111/j.1651-2227.1996.tb13945.x

M3 - Article

VL - 85

SP - 1418

EP - 1421

JO - Acta Paediatrica, International Journal of Paediatrics

JF - Acta Paediatrica, International Journal of Paediatrics

SN - 0803-5253

IS - 12

ER -